| Autor: |
Sujeta A; National Institute for Health Development, Lithuanian Sports University, Kaunas, Lithuania., Capkauskiene S; Department of Applied Biology and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania., Vizbaraite D; Department of Applied Biology and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania., Stasiule L; Department of Applied Biology and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania., Balciunas M; National Institute for Health Development, Lithuanian Sports University, Kaunas, Lithuania., Stasiulis A; Department of Applied Biology and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania., Kadusevicius E; Department of Clinical Pharmacology, Institute of Physiology & Pharmacology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania. |
| Jazyk: |
angličtina |
| Zdroj: |
International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition [Int J Vitam Nutr Res] 2020 Jan; Vol. 90 (1-2), pp. 67-83. Date of Electronic Publication: 2019 Apr 01. |
| DOI: |
10.1024/0300-9831/a000476 |
| Abstrakt: |
Omega-3 fatty acids and vitamin D3 have beneficial effects on different blood, cardiovascular parameters and physical performance. However, the effect of low-dose omega-3 fatty acid supplementation remains unclear. 84 office workers aged 40-60 years, participated in a 16-week open, randomized, placebo-controlled, parallel-group study. The experimental group received 330 mg of omega-3 fatty acid and 0.005 mg (200 IU) of vitamin D3 per day and the control group received placebo. Anthropometric, biochemical blood and respiratory indices were measured at 12 and 16 weeks. Body mass (BM) and body mass index (BMI) significantly reduced in both the experimental (BM from 74.4 ± 13.04 to 73.2 ± 13.02 kg, p < 0.001; BMI from 25.8 ± 4.1 to 25.4 ± 4.3 kg/m 2 , p < 0.001) and the placebo groups (BM from 69.5 ± 11. to 68.7 ± 11.4 kg, p < 0.05; BMI from 24.1 ± 4.0 to 23.8 ± 4.2 kg/m 2 , p < 0.05). Omega-3 fatty acid supplementation significantly improved glucose (from 5.12 ± 0.55 to 4.97 ± 0.62 mmol/l; p = 0.05), total cholesterol (from 5.86 ± 1.0 to 5.32 ± 1.55 mmol/l; p = 0.003), and vitamin D levels (from 35.07 ± 21.65 to 68.63 ± 25.94 nmol/l; p = 0.000). Maximal oxygen consumption (from 33.7 ± 2.4 to 36.6 ± 3.2 ml/kg/min, p = 0.035), forced vital capacity (from 3.5 ± 0.6 to 3.9 ± 0.9 l, p = 0.044), forced expiratory volume (from 3.2 ± 0.6 to 3.5 ± 0.7 l, p = 0.014), and peak expiratory flow (from 6.7 ± 1.4 to 7.5 ± 1.6 l/s, p = 0.019) also slightly improved in the omega-3 fatty acid group. Daily supplementation of 330 mg of omega-3 fatty acids had a slight positive impact on total cholesterol and glucose level, while there was no effect on low and high density lipoproteins, and triglycerides levels. Therefore, dose of 330 mg per day seems as insufficient. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
